150 related articles for article (PubMed ID: 30719219)
1. Correction: Incidence and risk of regorafenib-induced hepatotoxicity.
Zhao B; Zhao H
Oncotarget; 2019 Jan; 10(2):253. PubMed ID: 30719219
[TBL] [Abstract][Full Text] [Related]
2. Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib.
Zhao B; Zhao H
Oncotarget; 2019 Jan; 10(2):254. PubMed ID: 30719220
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk of regorafenib-induced hepatotoxicity.
Zhao B; Zhao H
Oncotarget; 2017 Oct; 8(48):84102-84111. PubMed ID: 29137408
[TBL] [Abstract][Full Text] [Related]
4. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
5. Correction: Dietary cholesterol intake and stroke risk: a meta-analysis.
Cheng P; Pan J; Xia J; Huang W; Bai S; Zhu X; Shao W; Wang H; Xie P
Oncotarget; 2018 Jun; 9(45):27907. PubMed ID: 29963247
[TBL] [Abstract][Full Text] [Related]
6. Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
Chen Y; Liu W; Wang P; Hou H; Liu N; Gong L; Wang Y; Ji K; Zhao L; Wang P
Oncotarget; 2018 Aug; 9(60):31787. PubMed ID: 30167094
[TBL] [Abstract][Full Text] [Related]
7. Correction: Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer.
Brüstle K; Heidecker B
Oncotarget; 2018 Sep; 9(70):33440. PubMed ID: 30279972
[TBL] [Abstract][Full Text] [Related]
8. Correction: Colon cancer-induced interleukin-35 inhibits betacatenin- mediated pro-oncogenic activity.
Jiang Y; Ma Y; Li R; Sun J
Oncotarget; 2018 Aug; 9(60):31788. PubMed ID: 30167095
[TBL] [Abstract][Full Text] [Related]
9. Correction: Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation.
Bettoun A; Joffre C; Zago G; Surdez D; Vallerand D; Gundogdu R; Sharif AAD; Gomez M; Cascone I; Meunier B; White MA; Codogno P; Parrini MC; Camonis JH; Hergovich A
Oncotarget; 2018 Apr; 9(32):22870. PubMed ID: 29854321
[TBL] [Abstract][Full Text] [Related]
10. Correction: Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1.
Yin SY; Efferth T; Jian FY; Chen YH; Liu CI; Wang AHJ; Chen YR; Hsiao PW; Yang NS
Oncotarget; 2018 Aug; 9(63):32271. PubMed ID: 30181816
[TBL] [Abstract][Full Text] [Related]
11. Correction: 6-Shogaol attenuates LPS-induced inflammation in BV2 microglia cells by activating PPAR-γ.
Han Q; Yuan Q; Xie G
Oncotarget; 2018 Jun; 9(44):27585. PubMed ID: 29938008
[TBL] [Abstract][Full Text] [Related]
12. Correction:
Guo W; Xu P; Jin T; Wang J; Fan D; Hao Z; Ji Y; Jing S; Han C; Du J; Jiang D; Wen S; Wang J
Oncotarget; 2018 Apr; 9(28):20221. PubMed ID: 29733083
[TBL] [Abstract][Full Text] [Related]
13. Correction: Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice.
Cai H; Wang Y; He J; Cai T; Wu J; Fang J; Zhang R; Guo Z; Guan L; Zhan Q; Lin L; Xiao Y; Pan H; Wang Q
Oncotarget; 2018 May; 9(39):25750. PubMed ID: 29877511
[TBL] [Abstract][Full Text] [Related]
14. Regorafenib induced severe toxic hepatitis: characterization and discussion.
Sacré A; Lanthier N; Dano H; Aydin S; Leggenhager D; Weber A; Dekairelle AF; De Cuyper A; Gala JL; Humblet Y; Sempoux C; Van den Eynde M
Liver Int; 2016 Nov; 36(11):1590-1594. PubMed ID: 27500989
[TBL] [Abstract][Full Text] [Related]
15. Correction: Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies.
Zhang S; Jia Z; Yan Z; Yang J
Oncotarget; 2018 Aug; 9(61):31937. PubMed ID: 30159134
[TBL] [Abstract][Full Text] [Related]
16. Correction: Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer.
Ahmed MA; Selzer E; Dörr W; Jomrich G; Harpain F; Silberhumer GR; Müllauer L; Holzmann K; Grasl-Kraupp B; Grusch M; Berger W; Marian B
Oncotarget; 2019 Sep; 10(51):5385-5386. PubMed ID: 31555396
[TBL] [Abstract][Full Text] [Related]
17. Correction: Molecular crosstalk between ferroptosis and apoptosis: Emerging role of ER stress-induced p53-independent PUMA expression.
Hong SH; Lee DH; Lee YS; Jo MJ; Jeong YA; Kwon WT; Choudry HA; Bartlett DL; Lee YJ
Oncotarget; 2018 May; 9(37):24869. PubMed ID: 29873322
[TBL] [Abstract][Full Text] [Related]
18. Correction: Long non-coding RNAs could act as vectors for paternal heredity of high fat diet-induced obesity.
An T; Zhang T; Teng F; Zuo JC; Pan YY; Liu YF; Miao JN; Gu YJ; Yu N; Zhao DD; Mo FF; Gao SH; Jiang G
Oncotarget; 2019 Jan; 10(7):798. PubMed ID: 30774781
[TBL] [Abstract][Full Text] [Related]
19. Correction: Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis.
Shin EA; Sohn EJ; Won G; Choi JU; Jeong M; Kim B; Kim MJ; Kim SH
Oncotarget; 2018 Jul; 9(55):30720. PubMed ID: 30093981
[TBL] [Abstract][Full Text] [Related]
20. Correction: Association of PDCD6 polymorphisms with the risk of cancer: Evidence from a meta-analysis.
Hashemi M; Bahari G; Markowski J; Małecki A; Łos MJ; Ghavami S
Oncotarget; 2020 Mar; 11(9):893. PubMed ID: 32180902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
